Delivery Order SPE2DB24D2109-SPE2DB25FHXRY
- Not listed
- The Defense Logistics Agency awarded a $10,662.57 delivery order to AmerisourceBergen Drug Corp on June 17, 2025, for the supply of Tagrisso 80 mg tablets (30-count packages). This firm fixed-price contract, with an ultimate completion date of July 10, 2025, represents a competitively awarded, non-set-aside procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and...
- The Defense Logistics Agency awarded a delivery order valued at $31,987.71 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award, with no set-aside designation, reflects firm fixed-price pricing terms and represents a pharmaceutical supply delivery to support federal medical procurement needs. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages). This competitive award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance of this contract will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $10,662.57 on September 16, 2025, for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 7, 2025, with performance taking place at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,641.07 to AmerisourceBergen Drug Corp for the supply of Tagrisso 40 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 24, 2025. The award was made on September 3, 2025, with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $21,325.14 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count) with a completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for Tagrisso 80 mg tablets (30-count packages). This contract utilizes firm fixed pricing with an ultimate completion date of August 11, 2025. The award was competitively awarded with no set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order represents a child contract under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Tagrisso 80 mg tablets (30-count units) valued at $10,662.57. This firm fixed price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation. AmerisourceBergen,...
- The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages) under a firm fixed price contract. The award was made on April 24, 2025, with an ultimate completion date of May 15, 2025, and was not set aside for any specific business category. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $21,325.14 for the supply of Tagrisso 80 mg tablets (30-count packages). This is a firm fixed-price delivery order with no set-aside designation, issued on September 4, 2025, with an ultimate completion date of September 25, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DB24D2109Indefinite Delivery Contract
- SPE2DB24D2109-SPE2DB25FHXRYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,662.57 to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages) under a firm fixed price contract type. This award, issued on August 12, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location. The pharmaceutical distributor is a critical vendor within the federal medical supply chain, providing a comprehensive range of brand-name and generic medications to support military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad spectrum of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical contract encompasses specialty medications, vaccines, syringes, and other critical medical commodities across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.7k | 8/12/25 |